Sara Bonstein

Sara Bonstein

Chief Financial OfficeratINSMED· In proxies 2021–2025

Pay in FY2025+15% from the year before · INSMED stock +152.1% the same year

Sara Bonstein was paid $4.6M in FY2025 (Dec), up 15%. INSMED stock rose 152.1% that year.

Pay$100 in the stock at the end of FY20 → $523
Pay is from the Summary Compensation Table of each INSMED proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. INSMEDPublic company · 5 yr
    • Chief Financial Officer2021 – Present · 5 yrStock in role +174%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?